References
- WHO. Global Tuberculosis Report 2020 [Internet] . 2020. [accessed 2020 Nov 3]. Available from: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
- Paramasivan CN, Venkataraman P, Chandrasekaran V, et al. Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis [Internet]. 2002;6(6):479–484. November 2001. http://Available from: https://pubmed.ncbi.nlm.nih.gov/12068979/.
- Ramachandran R, Nalini S, Chandrasekar V, et al. Surveillance of drug resistant Tuberculosis in state of Gujrat, India. Int J Tuberc Lung Dis [Internet]. 2009;13(9):1154–1160. http://Available from: https://pubmed.ncbi.nlm.nih.gov/19723407/.
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2008: RNTCP Status Report [Internet]. Available from: https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD..National Anti-TB Drug Resistance Survey.pdf [Internet] 2018.[accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/showfile.php?lid=3315
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD . India TB Report.2020 [Internet]. 2020.3538
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. In WHO; 2012. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/WriteReadData/l892s/8320929355 Guidelines for PMDT in India - May 2012.pdf
- Soyam V, Boro P. Newer initiatives in revised national tuberculosis control programme and its current implementation status. Asian J Med Sci [Internet]. 2015May;;65:1–8.Available from:https://nepjol.info/index.php/AJMS/article/view/11945/010.3126/ajms.v6i5.11945
- Chopra KK. Drug resistance among TB cases and its clinical implications. Indian J Tuberc [Internet]. 2015;62(3): 151–155. Available from: 10.1016/j.ijtb.2015.08.001.
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. DOTS-Plus Guidelines. 2010.
- Shrivastava S, Shrivastava P, Ramasamy J. Strengthening infrastructure in management of drug resistant tuberculosis in India. Prog Heal Sci [Internet]. 2014;4(1): 277–279. http://Available from: http://cejsh.icm.edu.pl/cejsh/element/bwmeta1.element.desklight-90220eaf-8f4b-4832-a927-5ea263d85100.
- World Health Organization. Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015. WHO Prog Rep [Internet]. 2011;1–127. http://Available from: https://www.who.int/tb/publications/2011/mdr_report_2011/en/.
- Government of India ND-PC. Final Minutes of the sixth DOTS ‐ Plus committee meeting held on 10th and 11th July 2009 at lRS Institute, New Delhi [Internet]. 2009. [accessed 2020 Jul 27]. Available from:https://tbcindia.gov.in/WriteReadData/l892s/3397296890 Final Minutes of the DPC meeting 10–11 july Final.pdf
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2009: RNTCP Status Report [Internet] 2009. Available from:https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2010: RNTCP Status Report [Internet] 2010 . Available from: https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2017: RNTCP Status Report. 2017;1–173. Available from: http://www.tbcindia.nic.in/WriteReadData/TB India 2017.pdf
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2011: RNTCP Status Report [Internet]. 2011. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807
- Government of India ND-PC. Minutes of the Seventh National DOTS-Plus Committee Meeting LRS Institute, New Delhi, 11th and 12th July 2011 [Internet]. 2011. p. 1–33. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/WriteReadData/l892s/302528588FinalMinutesof7thNationalDOTSPlusCommitteeMeeting-11-120711.pdf
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2013: RNTCP Status Report [Internet]. 2013. p. 2–223. Available from: https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807
- Raizada N, Sachdeva KS, Sreenivas A, et al. Feasibility of decentralised deployment of Xpert MTB/RIF test at lower level of health system in india. PLoS One. 2014;9(2). Available from: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089301&type=printable
- Raizada N, Sachdeva KS, Nair SA, et al. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. PLoS One. 2014;9(8). Available from:: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139368/pdf/pone.0105346.pdf
- Sachdeva KS, Raizada N, Sreenivas A, et al. Use of Xpert MTB/RIF in decentralized public health settings and its effect on pulmonary TB and DR-TB case finding in India. PLoS One. 2015;10(5):1–18. http://Available from: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0126065&type=printable.
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. Guidelines for PMDT in India - 2017 [Internet]. 2017. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/index1.php?lang=1&level=2&sublinkid=4780&lid=3306
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD.National Guideline for Partnership 2014 [Internet]. 2014. [accessed 2020 Jul 27]. Available from: http://tbcindia.gov.in/index1.php?lang=1&level=2&sublinkid=4252&lid=2899
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. Guidance Document on Partnerships. 2019. Last accessed on : 27th July 2020 https://tbcindia.gov.in/WriteReadData/l892s/9531588006Guidance%20Doucument%20on%20Partnerships%20RNTCP%202019.pdf
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. TB India 2014: annual Staus Report [Internet]. 2014. Available from: https://tbcindia.gov.in/index1.php?page=2&ipp=10&lang=1&level=1&sublinkid=4160&lid=2807
- Report on National Workshop on Drug Susceptibility Testing (DST) Guided Treatment for Drug Resistant Tuberculosis Patients in India. 2014;(August):1–45. Available from: https://tbcindia.gov.in/WriteReadData/l892s/713587265Report_ITRworkshop.pdf
- Arora VK, Chopra KK. Journey of tuberculosis control in India. Indian J Tuberc [Internet]. 2019 Jan;;66(1):178–183. Available from:https://pubmed.ncbi.nlm.nih.gov/30878065/.
- WHO. The use of bedaquiline in the treatment of multidrug-resistant tuberculosis: interim policy guidance [Internet]. 2013. [accessed 2020 Jul 27]. Available from: https://www.who.int/tb/publications/mdrtb-treatment-guideline/en/
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. National Strategic Plan for Tuberculosis: 2017–25 Elimination by 2025 2017;(March). [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/WriteReadData/NSP Draft 20.02.2017 1.pdf
- World Health Organization. Guidelines for use of Bedaquiline in RNTCP through conditional access under Programmatic Management of Drug Resistant Tuberculosis in India [Internet]. 2016. [accessed 2020 Jul 27]. Available from: https://www.tbcindia.gov.in/WriteReadData/l892s/8649978567selection.pdf
- Central TB Division, Directorate of health services, Ministry of Health & Family Welfare I, Bhawan N. India TB Report 2018 [Internet]. 2018. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/showfile.php?lid=3314
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. India TB Report 2019 [Internet]. 2019. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/WriteReadData/India TB Report 2019.pdf
- World Health Organization. Guideline for use of Delaminid in the Treatment of DRTB in India [Internet]. 2018. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/showfile.php?lid=3343
- Salhotra VS, Sachdeva KS, Kshirsagar N, et al. Effectiveness and safety of bedaquiline under conditional access program for treatment of drug-resistant tuberculosis in India: an interim analysis. Indian J Tuberc [Internet]. 2020;67(1):29–37.
- World Health Organisation. WHO treatment guidelines for drug- resistant tuberculosis 2016 [Internet]. World health organisation. 2016. [accessed 2020 Jul 27]. Available from: https://apps.who.int/iris/bitstream/handle/10665/250125/9789241549639-eng.pdf
- World Health Organization. Rapid Communication: key changes to the treatment of drug-resistant tuberculosis [Internet]. 2019. [accessed 2020 Jul 27]. Available from: https://www.who.int/tb/publications/2019/rapid_communications_MDR/en/
- Directorate of health services, Ministry of Health & Family Welfare,Government of India CTD. Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India 2019. 2019.
- World Health Organization. Report of the Joint Monitoring Mission: Revised National Tuberculosis Control Programme [Internet]. 2019. [accessed 2020 Jul 27]. Available from: http://tbcindia.nic.in/showfile.php?lid=3536
- World HealthOrganization .Antimicrobial resistance: Global Report on Surveillance [Internet]. 2014. [accessed 2020 Jul 27]. Available from: https://www.who.int/drugresistance/documents/surveillancereport/en/
- WHO. Global Tuberculosis Report 2018 [Internet]. 2018. [accessed 2020 Jul 27]. Available from: https://apps.who.int/iris/handle/10665/274453
- World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis [Internet]. 2014. [accessed 2020 Jul 27]. Available from: https://apps.who.int/iris/bitstream/handle/10665/130918/9789241548809_eng.pdf;jsessionid=67D55607B975C1F6420E309920475A0A? sequence= 1
- Parmar MM, Sachdeva KS, Dewan PK, et al. Unacceptable treatment outcomes and associated factors among India’s initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007–2011): evidence leading to policy enhancement. PLoS One. 2018 Apr;;13(4):1–24. Available from:.
- Suryawanshi SL, Shewade HD, Nagaraja SB, et al. Unfavourable outcomes among patients with MDR-TB on the standard 24-month regimen in Maharashtra, India. Public Heal Action [Internet]. 2017;7(2):116–122.
- Deshmukh RD, Dhande DJ, Sachdeva KS, et al. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tuberc [Internet]. 2018;651:41–47.
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. Direct Benefit Transfer Manual for National Tuberculosis Elimination Programme [Internet]. 2020. [accessed 2020 Jul 27]. Available from: https://www.tbcindia.gov.in/showfile.php?lid=3535
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. Revised Technical and operational Guidelines for TB.pdf [Internet]. 2016. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/index1.php?lang=1&level=2&sublinkid=4573&lid=3177
- Directorate of health services, Ministry of Health & Family Welfare, Government of India CTD. .State Initiatives on Patient Support Systems for TB Elimination in India [Internet]. 2018. [accessed 2020 Jul 27]. Available from: https://tbcindia.gov.in/WriteReadData/l892s/279399853 States Initiatives for Patient Support Systems for TB Elimination in India .pdf
- WHO. WHO Consolidated Guidelines on Drug-resistant Tuberculosis Treatment [Internet]. 2019. [accessed 2020 Jul 27]. Available from: https://apps.who.int/iris/bitstream/handle/10665/311389/9789241550529-eng.pdf?ua=1
- Rapid Response Plan to mitigate impact of COVID-19 Pandemic on TB Epidemic and National TB Elimination Program (NTEP) activities in India [Internet]. 2020. [accessed 2020 Jul 27]. Available from: https://www.tbcindia.gov.in/showfile.php?lid=3551
- Brhane Y, Gabriel T, Adane T, et al. Recent Developments and Novel Drug Delivery Strategies for the Treatment of Tuberculosis. Int J Pharm Sci Nanotechnol [Internet]. 2019;12(3):4524–4530. Available from:: https://www.researchgate.net/publication/335991851_Recent_Developments_and_Novel_Drug_Delivery_Strategies_for_the_Treatment_of_Tuberculosis
- Arinaminpathy N, Gomez GB, Sachdeva KS, et al. The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis. PLoS One. 2020;15(3):1–14. Available from: 10.1371/journal.pone.0230808.